2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Tranzyme, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ulimorelin Study of Efficacy and Safety (ULISES 008) Ulimorelin Intravenously (IV), Ulimorelin Invtravenously (IV), 5% dextrose in water - Gastrointestinal Dysmotility | Phase 3 | Completed | Tranzyme, Inc. | 330 | 2011-02-01 | 2012-07-26 |
| Ulimorelin Study of Efficacy and Safety (ULISES 007) Ulimorelin Intravenously (IV), 5% dextrose in water - Gastrointestinal Dysmotility | Phase 3 | Completed | Tranzyme, Inc. | 332 | 2011-01-01 | 2012-07-26 |
Romania (2) · United States (2) · Bulgaria (1) · Czechia (1) · France (1) · Hungary (1) · Italy (1) · Lithuania (1) · Poland (1) · Serbia (1) · United Kingdom (1)